Nirsevimab demonstrated protection against respiratory syncytial virus disease in healthy infants in Phase 3 trial marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.